Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of alzheimer's disease: Protection against and interruption of progression of amyloid and tau pathology and cognitive decline

Journal of Alzheimer's Disease

Volumn 30, Issue 1, 2012, Pages 183-208

  Clausen, Aaron ^a,c   Bi, Xiaoning ^b   Baudry, Michel ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Western University of Health Sciences   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Alzheimer's disease; amyloid ; antioxidants; fear conditioning; free radicals; learning; oxidative stress; superoxide dismutase catalase mimetics; tau

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; EUK 207; NUCLEIC ACID; OXIDOREDUCTASE; PRESENILIN 1; SUPEROXIDE CATALASE; SUPEROXIDE DISMUTASE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; FEAR; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84861516228     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111298     Document Type: Article

References (71)

1. Selkoe DJ (2001) Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81, 741-766. (Pubitemid 32267077)
2. Katzman R, Saitoh T (1991) Advancesin Alzheimer's disease. FASEB J 5, 278-286.
3. Salmon DP, Thomas RG, Pay MM, Booth A, Hofstetter CR, Thal LJ, Katzman R (2002) Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology 59, 1022-1028.
4. DeKosky ST, Scheff SW, Styren SD (1996) Structural correlates of cognition in dementia: Quantification and assessment of synapse change. Neurodegeneration 5, 417-421. (Pubitemid 27077903)
5. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706. (Pubitemid 21912142)
6. Cruts M, Van Broeckhoven C (1998) Presenilin mutations in Alzheimer's disease. Hum Mutat 11, 183-190. (Pubitemid 28132873)
7. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
8. Harman D (2006) Alzheimer's disease pathogenesis: Role of aging. Ann N Y Acad Sci 1067, 454-460. (Pubitemid 43806358)
9. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24, 1063-1070. (Pubitemid 37487883)
10. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421. (Pubitemid 36937044)
11. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 13, 1676-1687. (Pubitemid 23095409)
12. Geula C, Wu CK, Saroff D, Lorenzo A, Yuan M, Yankner BA (1998) Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med 4, 827-831. (Pubitemid 28331025)
13. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688. (Pubitemid 40320703)
14. Good PF, Werner P, Hsu A, Olanow CW, Perl DP (1996) Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 149, 21-28. (Pubitemid 26230974)
15. Butterfield DA, Hensley K, Cole P, Subramaniam R, Aksenov M, Aksenova M, Bummer PM, Haley BE, Carney JM (1997) Oxidatively induced structural alteration of glutamine syn-thetase assessed by analysis of spin label incorporation kinetics: Relevance to Alzheimer's disease. J Neurochem 68, 2451-2457. (Pubitemid 27218166)
16. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94, 9866-9868. (Pubitemid 27408156)
17. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68, 2092-2097. (Pubitemid 27176147)
18. Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 7, 548-554. (Pubitemid 33127140)
19. Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxida-tion and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23, 655-664. (Pubitemid 35217687)
20. Gabbita SP, Lovell MA, Markesbery WR (1998) Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem 71, 2034-2040. (Pubitemid 28491559)
21. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19, 1959-1964. (Pubitemid 29133374)
22. Lovell MA, Markesbery WR (2001) Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol 58, 392-396. (Pubitemid 32217455)
23. Nakanishi H, Wu Z (2009) Microglia-aging: Roles of microglial lysosome-and mitochondria-derived reactive oxygen species in brain aging. Behav Brain Res 201, 1-7.
24. Harris ME, Carney JM, Cole PS, Hensley K, Howard BJ, Martin L, Bummer P, Wang Y, Pedigo NW Jr, Butterfield DA (1995) Beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: Implications for Alzheimer's disease. Neuroreport 6, 1875-1879.
25. Yatin SM, Varadarajan S, Link CD, Butterfield DA (1999) In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42). Neurobiol Aging 20, 325-330; discussion 339-342. (Pubitemid 29525418)
26. Harris ME, Wang Y, Pedigo NW Jr, Hensley K, Butterfield DA, Carney JM (1996) Amyloid beta peptide (25-35) inhibits Na+-dependentglutamate uptakeinrathippocampal astrocyte cultures. J Neurochem 67, 277-286. (Pubitemid 26185607)
27. Varadarajan S, Yatin S, Aksenova M, Butterfield DA (2000) Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130, 184-208.
28. Avdulov NA, Chochina SV, Igbavboa U, O'Hare EO, Schroeder F, Cleary JP, Wood WG (1997) Amyloid beta-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes. J Neu-rochem 68, 2086-2091. (Pubitemid 27176146)
29. Tamagno E, Parola M, Guglielmotto M, Santoro G, Bardini P, Marra L, Tabaton M, Danni O (2003) Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic Biol Med 35, 45-58. (Pubitemid 36782336)
30. de la Monte SM, Neely TR, Cannon J, Wands JR (2000) Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell Mol Life Sci 57, 1471-1481.
31. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21, 3017-3023. (Pubitemid 32323483)
32. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106, 14670-14675.
33. Ma T, Hoeffer CA, Wong H, Massaad CA, Zhou P, Iadecola C, Murphy MP, Pautler RG, Klann E (2011) Amyloid beta-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. J Neurosci 31, 5589-5595.
34. Massaad CA, Washington TM, Pautler RG, Klann E (2009) Overexpression of SOD-2 reduces hippocampal superox-ide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106, 13576-13581.
35. Lee HP, Zhu X, Casadesus G, Castellani RJ, Nunomura A, Smith MA, Lee HG, Perry G (2010) Antioxidant approaches for the treatment of Alzheimer's disease. Expert Rev Neu-rother 10, 1201-1208.
36. Borger E, Aitken L, Muirhead KE, Allen ZE, Ainge JA, Con-way SJ, Gunn-Moore FJ (2011) Mitochondrial beta-amyloid in Alzheimer's disease. Biochem Soc Trans 39, 868-873.
37. Tillement L, Lecanu L, Papadopoulos V (2011) Further evidence on mitochondrial targeting of beta-amyloid and specificity of beta-amyloid-induced mitotoxicity in neurons. Neurodegener Dis 8, 331-344.
38. Mancuso M, Orsucci D, LoGerfo A, Calsolaro V, Siciliano G (2010) Clinical features and pathogenesis of Alzheimer's disease: Involvement of mitochondria and mitochondrial DNA. Adv Exp Med Biol 685, 34-44.
39. Muller WE, Eckert A, Kurz C, Eckert GP, Leuner K (2010) Mitochondrial dysfunction: Common final pathway in brain aging and Alzheimer's disease-therapeutic aspects. Mol Neurobiol 41, 159-171.
40. Dragicevic N, Smith A, Lin X, Yuan F, Copes N, Delic V, Tan J, Cao C, Shytle RD, Bradshaw PC (2011) Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction. J Alzheimers Dis 26, 507-521.
41. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, Reddy PH (2010) Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J Alzheimers Dis 20 (Suppl 2), S609-S631.
42. Picone P, Bondi ML, Montana G, Bruno A, Pitarresi G, Giammona G, Di Carlo M (2009) Ferulic acid inhibits oxidative stress and cell death induced by Afj oligomers: Improved delivery by solid lipid nanoparticles. Free Radic Res 43, 1133-1145.
43. Rhein V, Giese M, Baysang G, Meier F, Rao S, Schulz KL, Hamburger M, Eckert A (2010) Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure. PLoS One 5, e12359.
44. Simpkins JW, Yi KD, Yang SH, Dykens JA (2010) Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta 1800, 1113-1120.
45. Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, Zhu X, Smith MA (2010) Novel therapeutics for Alzheimer's disease: An update. Curr Opin Drug Discov Devel 13, 235-246.
46. Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, Van der Schyf CJ (2010) Oxidative stress and Alzheimer's disease: Dietary polyphenols as potential therapeutic agents. Expert Rev Neurother 10, 729-745.
47. Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, Humala N, Teplow DB, Pasinetti GM (2008) Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 28, 6388-6392.
48. Clausen A, Doctrow S, Baudry M (2010) Prevention of cognitive deficits and brain oxidative stress with superoxide dismutase/catalase mimetics in aged mice. Neurobiol Aging 31, 425-433.
49. Clausen A, Doctrow S, Baudry M (2010) Prevention of cognitive deficits and brain oxidative stress with superoxide dismutase/catalase mimetics in aged mice. Neurobiol Aging 31, 425-433.
50. Melov S, Doctrow SR, Schneider JA, Haberson J, Patel M, Coskun PE, Huffman K, Wallace DC, Malfroy B (2001) Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci 21, 8348-8353. (Pubitemid 33051432)
51. Morten KJ, Ackrell BA, Melov S (2006) Mitochondrial reactive oxygen species in mice lacking superoxide dismutase 2: Aattenuation via antioxidant treatment. J Biol Chem 281, 3354-3359. (Pubitemid 43845949)
52. Doctrow SR, Huffman K, Marcus CB, Tocco G, Malfroy E, Adinolfi CA, Kruk H, Baker K, Lazarowych N, Mascarenhas J, Malfroy B (2002) Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: Structure-activity relationship studies. J Med Chem 45, 4549-4558.
53. Bruce AJ, Baudry M (1995) Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free Radic Biol Med 18, 993-1002.
54. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, Oliveira CR (2008) Brain oxidative stressinatriple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 44, 2051-2057.
55. Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106, 274-285.
56. Kim JJ, Fanselow MS (1992) Modality-specific retrograde amnesia of fear. Science 256, 675-677.
57. Maren S, Aharonov G, Fanselow MS (1997) Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res 88, 261-274. (Pubitemid 27496322)
58. Riedel G, Harrington NR, Hall G, Macphail EM (1997) Nucleus accumbens lesions impair context, but not cue, conditioning in rats. Neuroreport 8, 2477-2481. (Pubitemid 27308446)
59. Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Mal-froy B, Baudry M (2003) Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci USA 100, 8526-8531. (Pubitemid 36842578)
60. Sung S, Yao Y, Uryu K, Yang H, Lee VM, Trojanowski JQ, Pratico D (2004) Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J 18, 323-325.
61. Altar CA, Baudry M (1990) Systemic injection of kainic acid: Gliosis in olfactory and limbic brain regions quantified with [3H]PK 11195 binding autoradiography. Exp Neurol 109, 333-341. (Pubitemid 20348964)
62. Apland JP, Figueiredo TH, Qashu F, Aroniadou-Anderjaska V, Souza AP, Braga MF Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala tosoman-induced neuropathology. Neurotoxicology 31, 485-492.
63. Miyata M, Smith JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxida-tive insults and beta-amyloid peptides. Nat Genet 14, 55-61. (Pubitemid 26301547)
64. Mazur-Kolecka B, Frackowiak J, Kowal D, Krzeslowska J, Dickson D (2002) Oxidative protein damage in cells engaged in beta-amyloidosis is related to apoE genotype. Neuroreport 13, 465-468. (Pubitemid 34293191)
65. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol58, 1985-1992. (Pubitemid 33143977)
66. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352, 2379-2388. (Pubitemid 40958434)
67. Sharpe MA, Ollosson R, Stewart VC, Clark JB (2002) Oxidation of nitric oxide by oxomanganese-salen complexes: A new mechanism for cellular protection by superoxide dismu-tase/catalase mimetics. Biochem J 366, 97-107. (Pubitemid 34971808)
68. Hinerfeld D, Traini MD, Weinberger RP, Cochran B, Doc-trow SR, Harry J, Melov S (2004) Endogenous mitochondrial oxidative stress: Neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J Neurochem 88, 657-667. (Pubitemid 38140210)
69. Smith MA, Casadesus G, Joseph JA, Perry G (2002) Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 33, 1194-1199. (Pubitemid 35246587)
70. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452. (Pubitemid 38495942)
71. Yan SD, Stern DM (2005) Mitochondrial dysfunction and Alzheimer's disease: Role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Int J Exp Pathol 86, 161-171. (Pubitemid 40813912)